본문 바로가기

Data Plus(+)

All 807,818 Page 19,935/80,782

검색

Contents

No Journal_name Subject Date DOI Author
608478 NEURO-ONCOLOGY CTNI-45. A PHASE 1B/2 CLINICAL STUDY OF NAPABUCASIN IN COMBINATION WITH TEMOZOLOMIDE FOR ADULT PATIENTS WITH RECURRENT OR PROGRESSED GLIOBLASTOMA MULTIFORME (GBM) | CTNI-45. A PHASE 1B/2 CLINICAL STUDY OF NAPABUCASIN IN COMBINATION WITH TEMOZOLOMIDE FOR A 2020-11-01 10.1093/neuonc/noaa215.211 Chi Andrew, DeRobles Paula, Foos Emma, Hitron Matthew, Mason Warren
608477 NEURO-ONCOLOGY EXTH-76. THE INOVIVO SYSTEM: A NOVEL PRECLINICAL TOOL FOR IN VIVO DELIVERY OF TUMOR TREATING FIELDS (TTFIELDS) | EXTH-76. THE INOVIVO SYSTEM: A NOVEL PRECLINICAL TOOL FOR IN VIVO DELIVERY OF TUMOR TREATING FIELDS (TTFIELDS) 2020-11-01 10.1093/neuonc/noaa215.430 Davidi Shiri, Blat Roni, Shteingauz Anna, Porat Yaara, Giladi Moshe, Weinberg Uri, Palti Yoram
608476 CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry 2020-11-01 10.1016/j.ctro.2020.10.003 Han James E., Chang John, Rosen Lane, Hartsell William, Tsai Henry, Chen Jonathan, Mishra Mark V., Krauss Daniel, Isabelle Choi J., Simone Charles B., Hasan Shaakir
608475 REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY: JOURNAL OF GREATPOLAND CANCER CENTER IN POZNÁN AND POLISH SOCIETY OF RADIATION ONCOLOGY Efficacy and safety of propolis mouthwash in management of radiotherapy induced oral mucositis; A randomized, double blind clinical trial 2020-11-01 10.1016/j.rpor.2020.09.012 Dastan Farzaneh, Ameri Ahmad, Dodge Samaneh, Hamidi Shishvan Hadi, Pirsalehi Ali, Abbasinazari Mohammad
608474 JOURNAL FOR IMMUNOTHERAPY OF CANCER Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma 2020-11-01 10.1136/jitc-2020-001681 Atkinson Victoria, Khattak Adnan, Haydon Andrew, Eastgate Melissa, Roy Amitesh, Prithviraj Prashanth, Mueller Christian, Brignone Chrystelle, Triebel Frederic
608473 JOURNAL FOR IMMUNOTHERAPY OF CANCER 803 Phase 1/2 study using ENB-003, a first-in-class selective ETBRi, in combination with pembrolizumab in subjects with advanced refractory solid tumors 2020-11-01 10.1136/jitc-2020-sitc2020.0803 Jamal Sumayah, Nagrial Adnan, Joshua Anthony, Eek Richard, Jamal Sumayah
608472 DRUG DESIGN, DEVELOPMENT AND THERAPY

Eldecalcitol Inhibits LPS-Induced NLRP3 Inflammasome-Dependent Pyroptosis in Human Gingival Fibroblasts by Activating the Nrf2/HO-1 Signaling Pathway

2020-11-01 10.2147/dddt.s269223 Huang Cancan, Zhang Chaotao, Yang Panpan, Chao Rui, Yue Ziqi, Li Congshan, Guo Jie, Li Minqi
608471 INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA Pattern and distribution of late Gadolinium enhancement in myocardium is an important predictor of clinical presentation in cardiac sarcoidosis: Observations from a single-center registry 2020-11-01 10.1016/j.ihj.2020.11.087 Vishnu S., Namboodiri Narayanan, Prabhu Mukund A., Nair Krishnakumar Mohanan, Anoop A., Valaparambil Ajitkumar
608470 BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE Effects of conditioned media from human umbilical cord blood-derived mesenchymal stem cells in the skin immune response 2020-11-01 10.1016/j.biopha.2020.110789 Kim Yoon-Jin, Ahn Hee-Jin, Lee Seung-Hee, Lee Mi-Hye, Kang Kyung-Sun
608469 BMJ OPEN Relationships among shift work, hair cortisol concentration and sleep disorders: a cross-sectional study in China 2020-11-01 10.1136/bmjopen-2020-038786 Zhang Yu, Shen Jiayang, Zhou Ziqi, Sang Lingli, Zhuang Xun, Chu Minjie, Tian Tian, Xiao Jing, Lian Yulong